High prevalence of thyroid disfunction in primary hyperaldosteronism;Alta prevalenza di disfunzioni della tiroide nell'iperaldosteronisino primario

Recenti Progressi in Medicina

Volumn 96, Issue 7-8, 2005, Pages 352-356

  Santori, Chiara ^a   Di Veroli, Claudio ^a   Di Lazzaro, Francesca ^a   Caliumi, Chiara ^a   Petramala, Luigi ^a   Cotesta, Dario ^a   Iorio, Monica ^a   Serra, Valentina ^a   Celi, Massimiliano ^a   D'Erasmo, Emilio ^a   Letizia, Claudio ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

Essential arterial hypertension; Hypertyroidism; Nodular goiter; Primary hyperaldosteronism; Thyroid diseases; Thyroid tumors; Thyroiditis

Indexed keywords

THYROID ANTIBODY; THYROTROPIN;

ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; ESSENTIAL HYPERTENSION; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; NODULAR GOITER; PREVALENCE; PRIMARY HYPERALDOSTERONISM; THYROID DISEASE; THYROID FUNCTION TEST; THYROID TUMOR; THYROIDITIS;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; ITALY; MALE; MIDDLE AGED; PREVALENCE; THYROID DISEASES; THYROID FUNCTION TESTS; THYROID HORMONES;

EID: 23144448752     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Conn JW. Primary aldosteronism: a new clinical syndrome. J Lab Clin Med 1955; 45: 6-17.
2. Conn JW, Cohen EL, Rovner DR, Nesbit RM. Normokalemic primary aldesteronism. A detectable cause of curable "essential" hypertension. JAMA 1965; 193: 200-6.
3. Ganguly A. Primary aldosteronism. N Engl J Med 1998; 24; 339: 1828-34.
4. Tucker R, Labarthe D. Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 through 1975. Mayo Clin Proc 1977; 52: 549-55.
5. Blumenfeld JD, Sealey JE, Schlussel Y, Vaughan EDJr, Sos TA, Atlas SA, et al. Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 1994; 121: 877-85.
6. Gordon RD. Mineralcorticoid hypertension. Lancet 1994; 344: 240-3.
7. Fardella CE, Mosso L, Gomez-Sanchez C, Cortès P, Soto J, Gomez L. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile and molecular biology. J Clin Endocrinol Metab 2000; 85: 1863-7.
8. Bravo EL. Primary aldosteronism. Issues in diagnosis and management. Endocrinol Metab North Am 1994; 23: 271-83.
9. Conn JW, Cohen BL, Rovner DR. Suppression of plasma renin activity in primary aldosteronism. JAMA 1964; 190: 213-21.
10. Bravo EL, Fouad-Tarazi FM, Tarazi RC, Pohl M, Gifford RW, Vidt DG. Clinical implications of primary aldosteronism with resistant hypertension. Hypertension 1988; 11 (suppl 1): 207-11.
11. Mallamaci F, Tripepi G, Caridi G. Hyperaldosteronism and simultaneus pheocromocitoma: a puzzle case. G Ital Nefrol 2002; 19: 184-98.
12. Tanaka M, Izeki M, Miyazaki Y, Horigome M, Yoneda T, Tsuyuki S, et al. Combined primary aldosteronism and Cushing's syndrome due to a single adrenocortical adenoma complicated Hashimoto's thyroidite. Intern Med 2002; 41: 967-71.
13. Omura M. Is it rare to have two adrenal disease combined? Intern Med 2002; 41: 911.
14. Hisamatsu H, Sakai H, Iru J, Moeda K, Kanetake H. Adrenocortical carcinoma with primary aldosteronism associated with Gushing syndrome during recurrence. BJU Int 2002; 90: 971-2.
15. Gea-Banaclochet J, Yebra Bango M, Berrocal Valencia E, Ruiz J. Primary hyperaldosteronism associated with primary, secondary or tertiary hyperparathyroidism? Med Clin (Barc) 1992; 98: 194.
16. Estopinan Garcia V, Fortea Gimeno L. Primary hyperparathyroidism and primary hyperaldosteronism: a rare case association. Med Clin (Barc) 1992; 98: 117.
17. Mychka VB, Chazova IE, Dimitriev W, Masenko VP. Role of hypothalamo-hypophysial-adrenal axis in the pathogenesis of arterial hypertension in patients with prolactinoma of the anterior of the hypophysis. Ter Arkh 2000; 72: 10-3.
18. Beckers A, Abs R, Willem PJ, Van Der Auwera B, Kovacs K, Reznik M, et al. Aldosterone-secreting adrenal adenoma as part of MEN1: loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN locus. J Clin Endocr Metabol 1992; 75: 564-70.
19. Duquenne M, Duriez T, Mathieu P, Aubert V, Weryha G, Leclere J. Primary hyperparathyroidism associated with multiple endocrine neoplasm. Presse Méd 1993; 22: 1746.
20. Caliumi C, De Toma G, Bossini A, Cianci R, Bosman C, Gennardi M, et al. A rare combination consisting of aldosterone-producing adenoma and adrenal myelolipoma in a patient with heterozygosity for retinoblastoma gene (RB). JRAAS 2004; 5: 45-8.
21. Iakovlev UA, Shustov SB, Khalimov IS. A case of Conn's syndrome combined with diffuse toxic goiter. Probl Endocrinol (Mosk) 1994; 40: 38-9.
22. Armanini D, Nacamulli D, Scaroni C, Lumache F, Selice R, Fiore C, et al. High prevalence of thyroid ultrasonographic abnormalities in primary aldosteronism. Endocrine 2003; 22: 155-9.
23. Marchant C, Brown L, Sernia C. Renin-angiotensin system in thyroid dysfunction in rats. J Cardiovasc Pharmacol 1993; 22: 449-55.
24. Montiel M, Jimenez E, Narvaez JA, Morell M. Renin-angiotensin-aldosterone system in hyper- and hypothyroid rats during sodium depletion. Endocr Res Commun 1982-83; 9: 249-60.
25. Cheol WP, Young SS, Seog JA, Suk YK, Eui JC, Byung KB. Thyroxine treatment induces up regulation of renin-angiotensin-aldosterone system due to decreasing effective plasma volume in patients with primary myxoedema. Nephrol Dial Trasplant 2001; 16: 1799-1806.
26. Fommei E, Iervasi G. The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans. J Clin Endocr Metab 2002; 87: 1996-2000.
27. Gordon RD: Primary aldosteronism. J Endocrinol Invest 1995; 495-511.
28. Bornstein SR, Stratakis CA, Chrousos GP. Adrenal tumors: recent advances in basic concepts and clinical management. Ann Intern Med 1999; 130: 759-71.
29. Bidey SP, Hill DJ, Eggo MC. Growth factors and goitrogenesis. Journal Endocrinol 1999; 160: 321-32.